Argemone ochroleuca: Biology, Pharmacological Potential and Perspectives
Torres-Gonalez Omar Ricardo1,Sanchez-Hernandez Ivan Moises1,Barragan-Alvarez Carla Patricia1,Flores-Fernandez Jose Miguel2,Padilla-Camberos Eduardo1*
Copyright : © 2018 Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Argemone ochroleuca is a native Mexican plant and now is widely distributed in tropical and subtropical regions of the world. It has a wide type of applications in traditional medicine. The plant contains alkaloids as the main active ingredients. Currently, research studies have begun to demonstrate their biological activity both for use in agriculture and in pharmacological applications.
1. Introduction
The “chicalote” is a plant that was used in the pre-Columbian culture of Mesoamerican peoples as an aid in the treatment of ocular, dermatological, respiratory, and diabetes problems. The first reference corresponds to the Florentine Codex of the sixteenth century, which relates in detail the use of latex to relieve eye pain; more over the naturalist Juan de Esteyneffer, at the beginning of the eighteenth century referred it in a medical compilation as a purgative remedy.
In the 20th century, the National Medical Institute indicates the following uses: antiescabietic, to treat dental problems, wound healing, and as regenerative, against dermatosis,
and eye problems. Other contemporary researchers such as Alfonso Herrera, and Maximino Martínez pointed out that the flowers, leaves, and juice of the plant are used in some diseases of the eyes and other activities as anticonvulsant, antidiarrheal, antispasmodic, antitussive, cathartic potential, to treat corneal spots, joint diseases, hypnotic, narcotic, and analgesic[14].
Although most of the scientific evidence is oriented to the biological activity of A.mexicana, there are some reports that refer to the use of the products obtained from A. ochroleuca, and are shown in table2.
The following is described according to the date of appearance in the scientific literature: A study showed the relaxant activity of the dichloromethane extract using the aerial parts in smooth muscle of guinea pigs; they obtained an IC50 value of 118,50 ± 3,91 μM and identifyed the presence of the compound Berberine as an active principle15. Alamri, and Moustafa in 201016 reported the antimicrobial activity of crude, and diluted latex using the plate diffusion method on strains such as Bacillus subtilis, Enterobacter aerogenes, Micrococcus luteus, Escherichia coli, and Staphylococcus aureus, showing their potential at the minimum inhibitory concentration (MIC) of 100μL / mL[16]. The research team showed too the antifungal activity of crude latex against 4 candida species isolated from patients (Candida albicans, Candida glabrata, Candida krusei and Candida tropicalis) and against 6 species of phytopathogenic fungi (Alternaria alternante, Drechslera halodes, Fusarium oxysporum, Macrophomina phaseolina, Pythium ultimum, and Rhizoctoina solani). They made the hexane extract of the latex, and analyzed by gas chromatography-mass spectrophotometry that revealed the presence of diethyl phthalate (81,57%), compounds of 6-nitro-imidazo (1,2-a) pyridine (8,833%), cyclohexasiloxane, dodecamethyl (5,607%), molecules of 4- (2,2-dimethyl-6-methylenecyclohexylidene)-3- methylbutan-2-one (2,410%) and cycloheptasiloxane, tetradecamethyl (1,574%)[17].
Reyes et al18 showed the antimicrobial activity of extracts of hexane, ethyl acetate, and methanol from aerial parts of A. ochroleuca. The antimicrobial activity was evaluated in thirteen bacterial, and nine fungal strains. Only methanol extract showed antimicrobial activity, strains of S. aureus (MIC = 125 μg / mL) and C. neoformans (MIC = 500 μg / mL) were the most sensitive to treatment. The research team identified and isolated the alkaloid Berberine present in the methanolic extract[18].
Martínez et al20 showed that the ethanolic extract (15 and 30%) inhibits the feeding and larval development of the “gusano cogollero” Spodoptera frugiperda. Finally, in 2017, Basharat observed possible allelopathic effects of the aqueous extract of A. ochroleuca on grasslands and farmland with species of wild plants native from Arabia: (Farsetia aegyptia and Salvia aegyptiaca L.) and plants used for forage (Hordeum vulgare L. and Medicago sativa L.) exhibiting sufficient allelopathic potential[20].
Although there are reports that describe the importance of the compounds identified in A. ochroleuca, the number of findings that support the study of A. mexicana (218 citations) exceeds the articles that analyze A.ochroleuca (20 citations). Both species are native to the Americas, however most of the reports found in the literature belong to research groups from the Asian continent, where these species were introduced. Al-Shanawany in 1996 mentioned that the indiscriminate use of A. mexicana, and A. ochroleuca in traditional Saudi medicine is due to the fact that they do not have significant morphological differences. Therefore, it is very important to update the taxonomic studies of the genus as well as to know the methods of identification that the researchers use to define the species in pharmacological studies.
References